Gilead Sciences Inc (GILD)
65.27
-1.81
(-2.70%)
USD |
NASDAQ |
Apr 25, 16:00
65.15
-0.12
(-0.18%)
After-Hours: 20:00
Gilead Sciences Cash from Investing (TTM): -2.265B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.265B |
| September 30, 2023 | -1.913B |
| June 30, 2023 | -2.397B |
| March 31, 2023 | -2.222B |
| December 31, 2022 | -2.466B |
| September 30, 2022 | -2.369B |
| June 30, 2022 | -1.89B |
| March 31, 2022 | -2.159B |
| December 31, 2021 | -3.131B |
| September 30, 2021 | -11.83B |
| June 30, 2021 | -11.87B |
| March 31, 2021 | -16.31B |
| December 31, 2020 | -14.62B |
| September 30, 2020 | -5.207B |
| June 30, 2020 | -6.777B |
| March 31, 2020 | -7.917B |
| December 31, 2019 | -7.817B |
| September 30, 2019 | -5.513B |
| June 30, 2019 | -1.647B |
| March 31, 2019 | 9.757B |
| December 31, 2018 | 14.36B |
| September 30, 2018 | 1.604B |
| June 30, 2018 | -2.535B |
| March 31, 2018 | -12.02B |
| December 31, 2017 | -16.07B |
| Date | Value |
|---|---|
| September 30, 2017 | -8.728B |
| June 30, 2017 | -10.53B |
| March 31, 2017 | -9.569B |
| December 31, 2016 | -11.98B |
| September 30, 2016 | -11.75B |
| June 30, 2016 | -12.02B |
| March 31, 2016 | -12.28B |
| December 31, 2015 | -12.48B |
| September 30, 2015 | -10.44B |
| June 30, 2015 | -7.026B |
| March 31, 2015 | -3.961B |
| December 31, 2014 | -1.823B |
| September 30, 2014 | -1.201B |
| June 30, 2014 | -439.27M |
| March 31, 2014 | -7.744M |
| December 31, 2013 | -254.00M |
| September 30, 2013 | -420.64M |
| June 30, 2013 | -930.65M |
| March 31, 2013 | -1.510B |
| December 31, 2012 | -11.85B |
| September 30, 2012 | -7.456B |
| June 30, 2012 | -7.018B |
| March 31, 2012 | -6.853B |
| December 31, 2011 | 3.590B |
| September 30, 2011 | -1.258B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-16.31B
Minimum
Mar 2021
-1.647B
Maximum
Jun 2019
-5.806B
Average
-3.131B
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Amgen Inc | -26.20B |
| Johnson & Johnson | 878.00M |
| Eli Lilly and Co | -7.153B |
| Pfizer Inc | -32.28B |
| CymaBay Therapeutics Inc (DELISTED) | -86.57M |